Background-Repeated doses of recombinant apolipoprotein A-I Milano phospholipid complex (apoA-I m ) reduce atherosclerosis and favorably change plaque composition in rabbits and mice. In this study, we tested whether a single high dose of recombinant apoA-I m could rapidly mobilize tissue cholesterol and reduce plaque lipid and macrophage content in apoE-deficient mice. Methods and Results-High cholesterol-fed, 26-week-old apoE-deficient mice received a single intravenous injection of saline (nϭ16), 1080 mg/kg dipalmitoylphosphatidylcholine (DPPC; nϭ14), or 400 mg/kg of recombinant apoA-I m complexed with DPPC (1:2.7 weight ratio; nϭ18). Blood was sampled before and 1 and 48 hours after injection, and aortic root plaques were evaluated for lipid content and macrophage content after oil-red O and immunostaining, respectively. One hour after injection, the plasma cholesterol efflux-promoting capacity was nearly 2-fold higher in recombinant apoA-I m -treated mice compared with saline and DPPC-treated mice (PϽ0.01). Compared with baseline values, serum free cholesterol, an index of tissue cholesterol mobilization, increased 1.6-fold by 1 hour after recombinant apoA-I m injection, and it remained significantly elevated at 48 hours (PϽ0.01). Mice receiving recombinant apoA-I m had 40% to 50% lower lipid content (PϽ0.01) and 29% to 36% lower macrophage content (PϽ0.05) in their plaques compared with the saline-and DPPC-treated mice, respectively. Conclusions-A single high dose of recombinant apoA-I m rapidly mobilizes tissue cholesterol and reduces plaque lipid and macrophage content in apoE-deficient mice. These findings suggest that this strategy could rapidly change plaque composition toward a more stable phenotype. (Circulation. 2001;103:3047-3050.)
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.